National Historical Financial Ratios
NHI Stock | USD 69.06 0.79 1.13% |
National Health is lately reporting on over 114 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 335 will help investors to properly organize and evaluate National Health Investors financial condition quickly.
National |
About National Financial Ratios Analysis
National Health InvestorsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate National Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on National financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across National Health history.
National Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing National Health Investors stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on National Health sales, a figure that is much harder to manipulate than other National Health Investors multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is National Health Investors dividend as a percentage of National Health stock price. National Health Investors dividend yield is a measure of National Health stock productivity, which can be interpreted as interest rate earned on an National Health investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from National Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into National Health Investors current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, National Health's Inventory Turnover is increasing as compared to previous years. The National Health's current Days Of Inventory On Hand is estimated to increase to 0.00003, while Price To Sales Ratio is projected to decrease to 7.26.
2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0696 | 0.0692 | 0.0645 | 0.0868 | Price To Sales Ratio | 8.79 | 8.4 | 7.58 | 7.26 |
National Health fundamentals Correlations
Click cells to compare fundamentals
National Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
National Health fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Price To Sales Ratio | 11.12 | 9.29 | 8.79 | 8.4 | 7.58 | 7.26 | |
Dividend Yield | 0.0508 | 0.0629 | 0.0696 | 0.0692 | 0.0645 | 0.0868 | |
Ptb Ratio | 2.28 | 2.36 | 2.04 | 1.74 | 1.84 | 1.93 | |
Days Sales Outstanding | 102.42 | 107.8 | 121.47 | 107.4 | 376.58 | 334.8 | |
Book Value Per Share | 34.51 | 34.07 | 33.18 | 28.81 | 29.36 | 16.5 | |
Free Cash Flow Yield | 0.063 | 0.0706 | 0.0802 | 0.0773 | 0.0746 | 0.0526 | |
Operating Cash Flow Per Share | 5.55 | 5.19 | 4.61 | 4.14 | 4.25 | 2.64 | |
Stock Based Compensation To Revenue | 0.0115 | 0.009197 | 0.0282 | 0.031 | 0.0144 | 0.0131 | |
Capex To Depreciation | 0.23 | 0.17 | 7.92E-4 | 0.0653 | 0.0535 | 0.0508 | |
Pb Ratio | 2.28 | 2.36 | 2.04 | 1.74 | 1.84 | 1.93 | |
Ev To Sales | 15.67 | 13.7 | 12.86 | 12.46 | 11.06 | 9.97 | |
Free Cash Flow Per Share | 5.14 | 4.88 | 4.61 | 4.04 | 4.16 | 4.37 | |
Roic | 0.0486 | 0.0536 | 0.0266 | 0.0118 | 0.0748 | 0.0982 | |
Net Income Per Share | 2.4 | 3.03 | 1.36 | 0.52 | 3.13 | 1.97 | |
Days Of Inventory On Hand | 3.13E-4 | 6.3E-5 | 16.4K | 3.1E-5 | 2.8E-5 | 3.0E-5 | |
Payables Turnover | 0.22 | 0.54 | 0.64 | 0.39 | 0.34 | 0.2 | |
Capex To Revenue | 0.0566 | 0.0416 | 2.14E-4 | 0.0166 | 0.0117 | 0.0111 | |
Cash Per Share | 0.12 | 0.97 | 0.82 | 0.43 | 0.52 | 0.49 | |
Pocfratio | 14.68 | 13.32 | 12.46 | 12.62 | 13.14 | 10.3 | |
Interest Coverage | 3.91 | 4.18 | 2.6 | 1.81 | 3.22 | 3.06 | |
Payout Ratio | 1.73 | 1.44 | 2.94 | 7.02 | 1.15 | 1.21 | |
Capex To Operating Cash Flow | 0.0747 | 0.0597 | 3.04E-4 | 0.025 | 0.0203 | 0.0193 | |
Pfcf Ratio | 15.87 | 14.16 | 12.46 | 12.94 | 13.41 | 12.74 | |
Days Payables Outstanding | 1.7K | 682.13 | 570.21 | 940.54 | 1.1K | 1.0K | |
Income Quality | 1.5 | 1.25 | 1.88 | 2.83 | 1.37 | 1.44 | |
Roe | 0.11 | 0.0695 | 0.0895 | 0.0413 | 0.0182 | 0.1 | |
Ev To Operating Cash Flow | 20.68 | 19.63 | 18.22 | 18.7 | 19.17 | 20.01 | |
Pe Ratio | 33.96 | 22.84 | 42.25 | 101.39 | 17.86 | 18.76 | |
Return On Tangible Assets | 0.0171 | 0.0217 | 0.011 | 0.004598 | 0.0545 | 0.079 | |
Ev To Free Cash Flow | 22.35 | 20.88 | 18.22 | 19.18 | 19.57 | 18.59 | |
Earnings Yield | 0.0294 | 0.0438 | 0.0237 | 0.009863 | 0.056 | 0.0754 | |
Net Debt To E B I T D A | 4.87 | 4.83 | 5.7 | 7.42 | 4.42 | 3.97 | |
Tangible Book Value Per Share | 104.58 | 103.89 | 95.28 | 84.81 | 29.36 | 25.58 | |
Receivables Turnover | 3.56 | 3.39 | 3.0 | 3.4 | 0.97 | 0.92 | |
Graham Number | 43.15 | 48.02 | 31.77 | 18.13 | 45.09 | 26.02 | |
Shareholders Equity Per Share | 34.49 | 33.83 | 32.97 | 28.37 | 28.9 | 16.43 |
Currently Active Assets on Macroaxis
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 2.91 | Revenue Per Share 7.598 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.